2,3,7,8-tetrachlorodibenzofuran has been researched along with Fatty Liver, Nonalcoholic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, G; Cheng, L; Dong, M; Lei, H; Ma, J; Song, Y; Xu, G; Yuan, P; Zhang, L | 1 |
1 other study(ies) available for 2,3,7,8-tetrachlorodibenzofuran and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
Targeted metabolomics reveals that 2,3,7,8-tetrachlorodibenzofuran exposure induces hepatic steatosis in male mice.
Topics: Animals; Benzofurans; Fatty Liver; Humans; Liver; Male; Metabolomics; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease | 2020 |